Woodline Partners LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $9.97 Billion distributed in 545 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $258M, Regeneron Pharmaceuticals, Inc. with a value of $191M, Ovintiv Inc. with a value of $190M, Te Connectivity Ltd. with a value of $161M, and Abb Vie Inc. with a value of $129M.

Examining the 13F form we can see an decrease of $518M in the current position value, from $10.5B to 9.97B.

Woodline Partners LP is based out at San Francisco, CA

Below you can find more details about Woodline Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $9.97 Billion
Healthcare: $4.13 Billion
Technology: $2.09 Billion
Energy: $837 Million
Financial Services: $735 Million
Industrials: $707 Million
Communication Services: $577 Million
Consumer Cyclical: $545 Million
Consumer Defensive: $223 Million
Other: $126 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 545
  • Current Value $9.97 Billion
  • Prior Value $10.5 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 188 stocks
  • Additional Purchases 181 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 154 stocks
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.